Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.08.04.502847

Probability Ramp Control reduces the number of sessions required to find an acceptable dose of succinylcholine during Electroconvulsive Therapy - an in silico analysis.

Abstract

IntroductionElectroconvulsive Therapy may be utilized in as many as 76,000 cases annually in the US, with the majority of cases employing succinylcholine. The reported dose spans the range of 0.29 - 2.1 mg/kg, and while motor seizures only last 36 {+/-} 6 seconds, the duration of paralysis extends to 310 {+/-} 38 seconds. While a model of succinylcholine pharmacokinetics/pharmacodynamics exists, this has not been employed to facilitate dose selection in clinical practice. Probability ramp control was investigated for this purpose. MethodsTwo approaches to dose finding were implemented. The first was an optimized Up-Down Method (UDM) that utilized an initial bolus, an adjustment dose, and a decrement to decrease the adjustment when crossing the target of 95% twitch depression. The second utilized probability ramp control (PRC) comprised of an infusion sequence that stopped when 95% twitch depression was obtained, a model that mapped the times for onset and offset of blockade to a subsequent bolus, and an adjustment dose to refine this dose when needed. Two populations of 10000 randomly parameterized models were developed from published data to train and evaluate the performance. Performance was assessed with a fuzzy classifier that segmented outcomes into three sets - LOW, HIGH, and SUCCESS. A loss function was developed that determined the number of sessions required to bring all models to SUCCESS. The probability distributions were compared using the Kolmogorov-Smirnov 2 sample test, with P<0.001 considered significant. ResultsOptimal values for the UDM parameters BOLUS, ADJUSTMENT, and DECREMENT were 0.7834 mg/kg, 0.3334 mg/kg, and 0.4056. Optimal values for the PRC SEQUENCE were 0.2663 mg/kg/min for 3 minutes followed by 0.7028 mg/kg/min. A fourth order polynomial MODEL produced estimates of the bolus that brought 99% of models to SUCCESS on the second session, while UDM required 6 sessions to achieve 99% SUCCESS. The probability distributions were distinct with P<<0.001. DiscussionPRC was able to correctly produce SUCCESS in significantly fewer sessions than UDM. Additionally, PRC is easy to implement and allows pooling of results from multiple clinicians. The performance of PRC in clinical use for ECT will require further study. Key Points QuestionCan probability ramp control reduce the number of ECT sessions with suboptimal succinylcholine dosing? FindingsProbability ramp control found the correct dose in two sessions in 99% of simulations, compared to six sessions for the Up-Down Method. MeaningProbability ramp control is a more efficient method for finding the appropriate dose of succinylcholine for repeated sessions of ECT.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Mandel, J. E.. 2022-08-05. Probability Ramp Control reduces the number of sessions required to find an acceptable dose of succinylcholine during Electroconvulsive Therapy - an in silico analysis.. https://doi.org/10.1101/2022.08.04.502847

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

SpiraMed: A Stereotactic Helix-based Therapy Delivery system for the Human Brain

Stereotactic needle-based delivery remains the standard for local administration of Advanced Therapy Medicinal Products (ATMPs) to the human brain. ATMP administration typically involves multiple trajectories, presenting cumulative risks and prolonging surgery. Reflux-prone, patchy therapy coverage compromises clinical results. We demonstrate a novel approach, deploying a helical delivery catheter via a single access trajectory per target, referred to as SpiraMed. Helix retraction is synchronised with therapy delivery, enabling comprehensive target coverage in seconds. Helix pitch and diameter can be precisely tailored to patient-specific target volume and vascular anatomy, as part of the preoperative stereotactic surgical planning process. Testing in agarose phantoms, live sheep and cadaveric human brain confirms enhanced therapy delivery volume, delivery speed and target coverage, with reductions in reflux and predicted risk of bleeding complication. SpiraMed represents a new paradigm, promising to help deliver on the transformative potential of cell and gene therapies across the spectrum of human CNS disease.

bioengineering↗

AtomWeaver: Multi-Component Flow Matching with a Structured Geometric Prior Facilitates Non-Canonical Peptide Design

Fixed-backbone sequence discovery, or inverse folding, is a critical recurring task in the development of new polypeptide therapeutics. Once promising backbones are established for a target pocket, computational inverse folding methods greatly help accelerate generation of candidate sequences. Such methods are mature for the traditional case of limiting to the fixed twenty-letter canonical vocabulary; however, they cannot access the broader space of non-canonical amino acids (NCAAs). This design constraint is exacerbated for peptide binders, a fast-growing modality that readily incorporates NCAAs, though in practice non-canonical design frequently depends on laborious medicinal-chemistry campaigns. An extension of inverse folding to NCAAs is thus critical to accelerating design of novel therapeutic peptides. AtomWeaver uses a joint all-site, atom-level generative scheme that does not restrict side-chain categorical assignment by either predetermined or co-resolving residue identity. Conditioned only on a fixed peptide backbone and its target protein, its multi-component flow guides side-chain atoms as unlabeled points in R3 from a nested shell prior to a variable-count final atom cloud. Identity is then read by matching each predicted cloud against a reference library of canonical and non-canonical templates. Since identity is decided only at decode time, the addressable vocabulary is a property of the library rather than of the trained weights: a new NCAA costs one reference structure and no retraining, and the model can select residues it was never prompted for and never saw in training. On a deep mutational scan of two peptide-target systems, AtomWeaver's canonical readout shows high observed mean agreement with experimental values among the compared inverse-folding methods. In the mixed canonical-noncanonical setting that canonical-only baselines cannot support at all, it likewise retains ranking signal across both systems. AtomWeaver also displayed self-consistent designs on de novo binder backbones, with the highest interface confidence among compared methods. Notably, it reached these metrics while achieving broad empirical coverage of our 300-residue vocabulary, including four non-canonical types never visible in training. AtomWeaver thus serves canonical and non-canonical peptide design alike, while transforming residue vocabulary to an expandable inference-time choice.

bioengineering↗

The Influence of Obesity and Body Shape on Sagittal Plane Knee Kinematics and Kinetics during Obstacle Crossing

Altered walking mechanics in individuals with obesity can contribute to knee osteoarthritis. The gait deviations may become more pronounced during obstacle crossing. In women, body fat distribution may further influence knee load, especially when excess fat accumulates in the thighs and hips. However, relatively little is known about how regional fat distribution affects gait in women with obesity. This study investigated how obesity and, among women, different fat distributions (Apple: more abdominal fat; Pear: more lower-limb fat) influence knee biomechanics during walking with and without obstacle crossing. Participants were 15 controls without obesity (NB) and 27 with obesity (OB). Within female participants, 10 without obesity (fNB) were compared with 20 with obesity, stratified by waist-hip ratio (Apple:10, Pear:10). Speed-adjusted statistical parametric mapping applied a general linear model (NB vs. OB) and an analysis of covariance (fNB vs. Apple vs. Pear). OB exhibited a significantly greater late-stance knee extension moment than NB across all tasks, and this difference persisted among fNB, Apple, and Pear in obstacle tasks (p<0.05). OB walked with reduced knee flexion during the early-stance leading limb after crossing a medium-height obstacle (p=0.048) and a high-height obstacle (p=0.008) compared to NB. There were significant body-shape effects (p<0.05), and post-hoc comparisons confirmed that Pear had lower knee angles than fNB in both leading-limb conditions after crossing medium- and high-height obstacles (p=0.008 and p=0.001, respectively). These findings suggest that obstacle crossing helps illuminate how excess weight influences knee biomechanics, and how regional fat distribution modulates the degree of this alteration.

bioengineering↗